TCRX TSCAN THERAPEUTICS INC

Ownership history in Mariner, LLC  ·  3 quarters on record

This page tracks every 13F SEC filing in which Mariner, LLC reported a position in TSCAN THERAPEUTICS INC (TCRX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 16,031 -1,023 -6.0% 0.00% $29K $1.82
2025 Q2 ADDED 17,054 +2,474 +17.0% 0.00% $25K $1.45
2025 Q1 INITIATED 14,580 0.00% $20K $1.38
% of Fund (quarterly)    TCRX price (monthly, adj. close)
← Back to Mariner, LLC Holdings